- Home
- NRC
as 07-26-2024 4:00pm EST
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
| Founded: | 1981 | Country: | United States |
| Employees: | N/A | City: | LINCOLN |
| Market Cap: | 548.0M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 153.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.24 | EPS Growth: | 2.48 |
| 52 Week Low/High: | $21.73 - $47.25 | Next Earning Date: | 08-06-2024 |
| Revenue: | $147,420,000 | Revenue Growth: | -1.46% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of National Research Corporation (Delaware) (NRC)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Common Property Trust | NRC | 10% Owner | Mar 1 '24 | Sell | $40.54 | 598,653 | $24,269,392.62 | 3,854,284 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Jan 4 '24 | Sell | $41.22 | 4,600 | $189,617.06 | 3,833,976 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Jan 4 '24 | Sell | $40.20 | 2,614 | $105,092.47 | 3,831,362 | SEC Form 4 |
| Common Property Trust | NRC | 10% Owner | Jan 3 '24 | Sell | $41.53 | 364,625 | $15,142,876.25 | 4,452,937 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Jan 2 '24 | Sell | $40.21 | 180,500 | $7,257,959.15 | 3,979,315 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Jan 2 '24 | Sell | $41.18 | 20,600 | $848,287.40 | 3,958,715 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Jan 2 '24 | Sell | $41.77 | 120,139 | $5,018,758.67 | 3,838,576 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Dec 12 '23 | Sell | $41.55 | 21,884 | $909,282.39 | 4,164,194 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Dec 12 '23 | Sell | $41.55 | 3,779 | $157,027.28 | 4,160,415 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Dec 12 '23 | Sell | $41.59 | 600 | $24,954.48 | 4,159,815 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Dec 7 '23 | Sell | $41.56 | 4,738 | $196,930.71 | 4,236,044 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Dec 7 '23 | Sell | $41.55 | 12,328 | $512,228.40 | 4,223,716 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Dec 7 '23 | Sell | $41.56 | 37,638 | $1,564,047.09 | 4,186,078 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Dec 4 '23 | Sell | $41.60 | 100 | $4,160.00 | 4,243,232 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Dec 4 '23 | Sell | $41.60 | 1,498 | $62,316.80 | 4,241,734 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Dec 4 '23 | Sell | $41.60 | 952 | $39,603.20 | 4,240,782 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Nov 20 '23 | Sell | $42.10 | 57 | $2,399.70 | 4,244,059 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Nov 20 '23 | Sell | $42.05 | 100 | $4,205.00 | 4,243,959 | SEC Form 4 |
| Amandla MK Trust | NRC | 10% Owner | Nov 20 '23 | Sell | $42.08 | 627 | $26,382.03 | 4,243,332 | SEC Form 4 |
Latest National Research Corporation (Delaware) News
NRC Breaking Stock News: Dive into NRC Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12
Business Wire
2 months ago
Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
GlobeNewswire
2 months ago
Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
GlobeNewswire
2 months ago
Share buy-back programme - week 23
Simply Wall St.
2 months ago
Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?
Reuters
2 months ago
Japan's service sector mood hits nearly 2-year low in May
AFP
2 months ago
N. Korea sends more balloons as Kim's sister warns of 'new counteraction'
PR Newswire
2 months ago
Enduring role of 'treasuring the past' hailed
Compare NRC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NRC National Research Corporation (Delaware) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.